Details on the selection of variables for the iScore, data sources, and creation and conceptualization of the iScore have been published elsewhere. 7 The risk scoring system is presented in Table I in the online-only Data Supplement.
A cute ischemic stroke causes substantial morbidity and mortality. To be able to accurately estimate the risk of death in patients with stroke is important in many ways. It may help the healthcare provider and family make decisions on a treatment plan, discharge arrangement, and resource use. However, most previously published models predicting short-term or long-term mortality after ischemic stroke have not been externally validated 1, 2 and are difficult to implement. [3] [4] [5] [6] On the contrary, the iScore system may serve this purpose well because it uses easy-to-collect clinical parameters and comorbid conditions. 7 The iScore was developed and validated in Western populations. To assess the accuracy and usability of the iScore in an Asian population, we applied it to the patients whose data were included in the China National Stroke Registry (CNSR).
Methods
The CNSR recruited 22 216 consecutive eligible patients from 132 participating acute care hospitals between September 2007 and August 2008. The steering committee selected hospitals from different regions to ensure the representation of each of the 27 provinces and 4 municipalities in Mainland China. All patients or their designated relatives gave written consents when enrolled. 8 A standardized data collection tool was developed by the steering committee. Paper-based registry forms were used for data collection. Information was collected through face-to-face interview and from medical records by trained research coordinators.
Stroke severity was assessed on admission by using the National Institutes of Health Stroke Scale (NIHSS), which was then converted to the Canadian Neurological Scale (CNS). 9 For the purpose of this study: an NIHSS score of 14 to 22 equals a CNS score of 1 to 4 (severe), 7 an NIHSS score of 9 to 13 equals a CNS score of 5 to 7 (moderate), 7 an NIHSS score of ≤8 equals a CNS score of ≥8 (mild), 7 and an NIHSS score of >22 equals a CNS score of 0 (a score of 0 was assigned to patients in a coma). 7 All ischemic stroke subtypes classified by the Trial of Org 10172 in Acute Stroke Treatment criteria 10 were included in the present study.
Eligibility Criteria
The cohort used in the present study from CNSR included patients who were ≥18 years of age with a primary diagnosis of acute ischemic stroke. Patients diagnosed with transient ischemic attack or hemorrhagic strokes were excluded. Patients with missing baseline characteristics (eg, age, NIHSS score, glucose on admission, and date last seen normal before the index event; n=593; 4.78%) or without follow-up outcomes were excluded. The study of CNSR was approved by the Central Institutional Review Board at Beijing Tiantan Hospital.
Outcome Measures
The main outcomes of interest were 30-day mortality and 1-year mortality.
Statistical Analyses
The baseline characteristics between the CNSR and the Registry of the Canadian Stroke Network cohorts were compared using the χ 2 test for the categorical variables, Student t test for the means, or Kruskal-Wallis test for the medians for the continuous variables. When needed, Yates correction or Fisher exact test were used for categorical data. The calculation of patients' iScore was performed in a manner identical to that reported in the original article. 7 Variables included in the iScore used to predict mortality at 30 days included age, sex, CNS, stroke subtype (lacunar, nonlacunar, and undetermined), preadmission independence, glucose on admission, and presence of atrial fibrillation, congestive heart failure, cancer, or renal failure (on dialysis). In addition to these variables, history of myocardial infarction and current smoker were included in the iScore for predicting mortality at 1 year. We used iScore quintiles to divide the CNSR cohort into 5 risk categories. 7 Logistic regression model was used to assess the performance of the iScore for predicting 30-day and 1-year mortality. The model discrimination was assessed by the C statistic. The curve of receiver-operating characteristic was also drawn. The C statistic is equivalent to the area under the receiver-operating characteristics curve and is equivalent to the probability that the predicted risk of death is higher for patients who died than for patients who survived.
11 A C statistic of 1.0 indicates perfect prediction, whereas a C statistic of 0.5 indicates no better than random prediction. Calibration was assessed using Hosmer-Lemeshow goodness-of-fit χ 2 test. However, because Hosmer-Lemeshow test is known to be oversensitive to small deviations from good fit in large samples, we compared predicted versus observed mortality at the risk score level using Pearson correlation coefficient. The observed and predicted mortality rates were plotted as continuous function of the risk scores.
All analyses were conducted using SAS statistical software (Version 9.2, SAS Institute Inc, Cary, NC).
Results
Among the 22 216 patients enrolled in the CNSR, there were 12 415 ischemic stroke patients who consented for the followup. After excluding patients with missing baseline characteristics (n=593; 4.78%) and patients with missing follow-up outcome data (n=166; 1.34% for 30-day follow-up and n=771; 6.21% for 1-year follow-up), 11 656 patients with complete 30-day follow-up and 11 051 patients with complete 1-year follow-up information were entered into the final analyses. Comparing the demographics of Chinese patients with ischemic stroke with patients in the Registry of the Canadian Stroke Network (Table 1) , Chinese patients were younger (median, 67 versus 75; mean, 65.5 versus 72.0), more likely to be men (61.8% versus 52.6%), had less severe strokes (CNS, ≤4; 14.6% versus 19.5%), and a lower mortality rate at 30 days (5.4% versus 12.2%) and at 1 year (14.3% versus 22.5%).
Risk Score
The iScore in both cohorts (cohort with 30-day follow-up and cohort with 1-year follow-up in CNSR) was not normally distributed, with median scores of 112 (quartiles 1-3, 95-140) at 30 days and 94 (quartiles 1-3, 80-114) at 1 year. Quintiles of the original iScore were used to divide the cohorts into 5 risk groups. The risk of mortality increased by quintile of risk score, from 1.2% for quintile 1 to 27.0% for quintile 5 for the mortality rate at 30 days, and from 3.4% for quintile 1 to 57.8% for quintile 5 for the mortality rate at 1 year ( Figure 1A and 1B) .
When analyzing the predictability of the iScore by comparing the step-by-step modeling (Figure 2A and 2B) , some simpler risk models adjusted for fewer risk factors (age and stroke severity) 12, 13 could not discriminate patients with the same age and stroke severity. However, there was a difference if other clinical characteristics or medical history was added to the calculation. For example, in low-risk category (70 years of age with a moderate stroke), the addition of hyperglycemia (>135 mg/dL; +15 points), male sex, and atrial fibrillation (+10 points each) would double the predicted 30-day mortality rate from 7.09% to 13.84% ( Figure 2A ). It is more impressive when predicting 1-year mortality rate, from 25.31% (derived from the model, including only 60 years of age and severe stroke) to 71.21% by adding dialysis (+40 points) and to 83.39% by adding male sex (+5 points) and dependency (+20 points; Figure 2B ).
Discrimination and Calibration of the iScore In CNSR Cohorts
In the CNSR, the C statistics were 0.825 (95% confidence interval, 0.807-0.843; Figure 
Discussion
The results of this study suggest that the predicted and observed mortalities in the CNSR cohorts were in close agreement across the entire spectrum of risk based on the iScore. The iScore is of high predictive value for the short-term and long-term mortality of patients with ischemic stroke in China (C statistics, 0.825 and 0.822 for 30-day and 1-year mortality, respectively). The iScore showed an incremental effect: the higher the score, the higher the risk of death.
Although many differences were observed in demographic characteristics and risk factors between the CNSR and Registry of the Canadian Stroke Network data sets (Table 1) , iScore predicted mortality rate well in patients with ischemic stroke entered into the CNSR (Figures 1 and 3) , despite the
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patients in the CNSR having overall lower mortality rate than those in the Registry of the Canadian Stroke Network (5.4% versus 12.2% at 30 days and 14.3% versus 22.5% at 1 year).
Patients with ischemic stroke in the CNSR were younger and had lower stroke severity (Table 1) , which was likely the reason why the CNSR showed lower mortality.
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Furthermore, we demonstrated that the inclusion of additional relevant clinical information, such as atrial fibrillation, renal failure, cancer, and congestive heart failure, for the predictability for 30-day and 1-year mortality (Figure 2 ) was very different comparing with only age and stroke severity to be included. 12, 20, 22, 23 Previous studies have predicted stroke outcomes by incorporating different clinical information. One report showed good discrimination (C statistics, >0.80) for a devastating outcome at 3 months (NIHSS, ≥20 or death; Barthel Index, <60 or death; or Glasgow Outcome scale, >2) by including initial NIHSS score, stroke subtype, history of diabetes mellitus or stroke, preadmission status, and infarct volume determined on computed tomography 7 to 10 days after stroke. 13 This study did not generate a useful score. Other studies had small sample sizes. 15 Williams and Jiang 24 attempted to develop a To convert glucose to mg/dL, divide by 0.0555. We used χ 2 tests to compare categorical variables and ANOVA or Kruskal-Wallis tests to compare mean and median differences for continuous variables in baseline characteristics.
CAD indicates coronary artery disease; CHF, congestive heart failure; CNS, Canadian Neurological Scale; and Q, quartile.
*A score of 0 was assigned for the CNS if participants were in a coma. survival score to predict 12-month mortality by using clinical variables in 453 patients with stroke. Their purpose was to determine the functional status and disability, but the score was not externally validated. Other prognostic models demonstrated good discrimination (C statistics, 0.70-0.85) 1, 2, 12, 14, 20, 22 in determining mortality, but many relevant clinical conditions, such as atrial fibrillation, renal failure, cancer, and congestive heart failure were omitted (Figure 2 ). Their scorings were not externally validated. The iScore was designed to be valid independent of stroke volume and specialized laboratory tests. It is an easy-touse model compared with most other predictive risk models. Therefore, it can be used at small centers with limited resources to estimate both short-term (30 days) and long-term (1 year) mortality after stroke.
Our study has several limitations. First, in the CNSR data set, the selection of participating hospitals, although covering all areas of China, was done for their ability of being capable of providing comprehensive care and collecting the data. Therefore, all of the hospitals were from urban regions of China. These study sites may represent institutions with more resources and expertise than those in rural area. The applicability of the iScore to all hospitals in China merits further investigation. Second, the iScore does not include information on imaging or laboratory studies, which may affect the outcomes of patients. 7, 25 Third, both derivation and validation populations consisted of only hospitalized patients with acute ischemic stroke. Consequently, the iScore may not apply to patients with nonischemic stroke. Subsequent studies are required to explore its use in patients with transient ischemic attack or intracerebral hemorrhage. Finally, the conversion from NIHSS to CNS is arbitrary and may have influenced the performance of the iScore in this population. Nevertheless, the successful validation of the iScore in Chinese patients with ischemic stroke showed that such influence may have been minimal.
In conclusion, the iScore can be applied reliably to different patients with ischemic stroke entered into the CNSR. The iScore is a valid and easy-to-use clinical tool to predict mortality in Chinese patients with ischemic stroke. The curve of receiver operating characteristics with C statistic of 0.822 for 1-year mortality.
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